About Me
I'm a pharma-tech founder who learned hard lessons the hard way. Over 22 years, I built five companies: four exits, one glorious flop. Customers ranged from Israeli medical device startups to Verily, Amgen and the Fortune 1 company.

I work with a small number of well-funded life science executives using an inversion methodology based on 23 identified anti-design patterns. Instead of generic startup playbooks, we identify what's killing your competitive position and systematically remove the blockers to success.

If you're a Series A+ life science company dealing with competitive positioning challenges, let's talk.
Book a 15' intro call.
Life Sciences Today podcast

I host the podcast to bring you in-depth conversations with founders at the intersection of AI, tech and biology. My guests and I reveal the patterns behind sustainable competitive advantages.

The podcast is part of the by Healthcare IT Today network with a readership of over 100,000 people
Watch the podcast

Testimonials
Bob and Alice - an anti-love story
  • My latest book is a love story with twists into tech startups and international terror financing.

    Bob and Alice is a thrilling journey into the hearts of two high-performing individuals, each navigating the shadows of their own fears and the demands of their careers. Bob, a Silicon Valley CTO, and Alice, a fiercely dedicated FBI lawyer, find themselves entangled in a web of international intrigue, personal challenges, and the unpredictable currents of love.

    Between high-stakes missions and intimate moments, Bob and Alice explores the profound truth that a relationship thrives when both man and woman share the load, trusting each other to stand strong in their own moments of vulnerability.
Book a call

I help a small group of TechBio entrepreneurs grow revenue by solving the tech, team, and go-to-market bottlenecks that stall progress. If you want to level up performance—without burning out yourself, your team, or your margin—let’s talk.


Writing

Are you building a well-funded life science company and need strategic clarity beyond generic startup advice?

The Clear Thinking newsletter reveals the patterns behind sustainable competitive advantages. I draw on 45+ interviews with successful techbio and pharma founders on the Life Sciences Today podcast, plus systematic analysis of the patterns and anti-patterns of a profitable and defensible TechBio business.

The Friday essay is trusted by a network of leaders from Lindus Health, Menarini, Merck, IQVIA, Medtronic, Flatiron Health, Debiopharm and many more.

We live by My Incomplete Manifesto of 5 core values:

Clarity

We speak plainly. No fluff, no jargon. Strong ideas don’t need gobbledy.

Simplicity

We make complex problems solvable by stripping away what doesn’t matter.

Workmanship

We take pride in what we build. Craft is not a luxury — it’s the job.

Respect

We honor attention. We respect your time. Trust is earned.

Consistency

We show up. Not once. Every time. That’s how progress happens.



Subscribe


Here are some stories you don’t want to miss:
Subscribe